Skip to main content

Libre Policy Links

The England CCG Policies - as at 15/10/18 (and in the public domain!)

RMOC Guidance

BaNES and Wiltshire
Barnet and North London
Barnsley
Bradford, Calderdale, Greater Huddersfield, North Kirklees, Wakefield (new November '18)
Brighton, Hove & High Weald
Bristol
Birmingham/Solihull and Sandwell
Cambridge & Peterborough
Canterbury and Coastal
Coastal West Sussex
Dorset
Dudley
East Berkshire
East Cheshire, South Cheshire, Vale Royal
East of England (now superseded)
East of England Adult September 2018
East of England Child September 2018
East Riding & Hull
Erewash, Hardwick, North and South Derbyshire
North and East Lincs APC Extract from mins
Lancashire (Blackburn, Blackpool, Chorley, E Lancs, Preston, Morecambe Bay, W Lancs, Fylde)
Lincolnshire (4 CCGs)
Hackney
Hambleton, Richmond and Whitby
Harrogate
Havering
Herefordshire
Kernow
Leeds - minutes with mention of Libre
Leeds Policy
Leicestershire (now superseded)
Leicester (released 21/12/18)
Manchester
Merton
Mid Essex (EoE but not funded)
NE Hampshire and Farnham
Nene
N, E, W Devon, S Devon, Torbay
NE England including Newcastle
Nottingham City, N, E, W Notts, Rushcliffe & Newark
NW London
Oxford & Thames Valley
Pan Mersey
Portsmouth S Hants, IOW Pathway
Portsmouth, S Hant, IOW Policy
Rotherham
Sheffield
Shropshire
Somerset
South London
South Staffordshire
South Yorkshire Statement
Surrey
Telford
Tower Hamlets, Waltham Forest, Newham
Warwickshire North
West Suffolk
Worcestershire
York & Scarborough


Comments

Popular posts from this blog

Abbott dX 2022 Barcelona - "Make it Count"

For the past four years I've been invited by Abbott to a conference bringing together people with diabetes from across Europe to discuss various topics.  The first year I was meant to attend, it was my 'man v horse' year (the horse won!), so was unable to attend and then the pandemic hit so two further dX's were held virtually.  I was fortunate to be asked to present at last year's session.  This year's event was back in-person and held in Barcelona, coinciding with the latter part of the ATTD conference.   At this point, I must make it very clear - Abbott invited me to the 2022 European Diabetes Exchange forum (dX), that took place in Barcelona.  I attended this two-day event to connect and interact with inspirational and influential people in the diabetes community.  Abbott paid for my ticket and accommodation. #InvitedbyAbbott.  This is formal and it needs to be - I have not been required to do anything by Abbott as a result of my attendance and I hope that m

The CCG Project!

In order to find out the situation around the country for Libre prescribing now that the national policy has been published, I have made the decision to contact many of them to find out their plans.  I have arbitrarily chosen to contact all English CCGs that in December 2018 prescribed Libre via Primary Care to less than 5% of their population (and one specific request from a group member).  I had hoped this would be a small list, but there are 135 CCGs on the list.  I may have bitten off more than I can chew, but I'm committed to doing this and feeding back.  It worked before and hopefully this level of scrutiny will bring similar results. Below is a screenshot of the base document I am sending to each of the CCGs - it has some fields that are merge fields, so don't worry about the brackets and codes in the document (I found a typo, which has now been corrected too) .  The major piece of work with respect to this is finding the right person to contact.  However, I have s

July Update - CCGs Under Pressure!

The heat is unbearable in some parts, not only in the environment, but also hopefully the heat directed at the decision-makers in 'non-compliant' CCGs who are either refusing to accept that Libre is a revolutionary tool for many T1s or have agreed to fund, but then set crippling criteria. Latest Prescribing Data Progress in prescribing continues, with stabilisation in Scotland and a continuation of the steady rise in the other three countries of the UK.  The Wales May data should be out this week. As mentioned last month, the situation in Scotland is particularly promising and the excellent Edinburgh Centre for Endocrinology and the Scottish Health Technologies Group have published documents that should significantly help the Libre case.  These documents are based on the first six months of prescribing Libre. Healthcare Improvement Scotland Statement Flash Glucose Monitoring is associated with improved glycaemic control and quality of life in people with type 1 d